Design Therapeutics Q2 EPS $(0.34) Misses $(0.33) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings MissesNews
Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.33) by 3.03 percent. This is a 61.9 percent decrease over losses of $(0.21) per share
Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.33) by 3.03 percent. This is a 61.9 percent decrease over losses of $(0.21) per share from the same period last year.